GM-CSF blockade with mavrilimumab in severe COVID-19...

  • Main
  • 2020 / 6
  • GM-CSF blockade with mavrilimumab in severe COVID-19...
The Lancet Rheumatology 2020 / 6

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study

De Luca, Giacomo, Cavalli, Giulio, Campochiaro, Corrado, Della-Torre, Emanuel, Angelillo, Piera, Tomelleri, Alessandro, Boffini, Nicola, Tentori, Stefano, Mette, Francesca, Farina, Nicola, Rovere-Quer
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Lancet Rheumatology
DOI:
10.1016/S2665-9913(20)30170-3
Date:
June, 2020
File:
PDF, 930 KB
2020
Conversion to is in progress
Conversion to is failed